Stock 8622 HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Huakang Biomedical Holdings Company Limited

Equities

8622

KYG4644W1069

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E.
Other stock markets
 04:08:06 2024-04-30 am EDT 		5-day change 1st Jan Change
0.098 HKD -5.77% Intraday chart for Huakang Biomedical Holdings Company Limited -1.01% -8.41%
Mar. 28 Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Year Ended 31 December 2023 CI

Business Summary

Huakang Biomedical Holdings Co Ltd is an investment holding company mainly engaged in the production and sales of in-vitro diagnostic reagents. The Company operates its business through two segments. The Biological Reagents and Auxiliary Reproductive Supplies and Equipment segment is engaged in the research and development, production, marketing and sales of in-vitro diagnostic reagents, including male infertility in vitro diagnostic reagents, parasite series detection reagents and Epstein-Barr (EB) virus detection reagents. The Segment is also engaged in the manufacture and sale of auxiliary reproductive supplies and devices. The Healthcare Products and Supplements segment is engaged in the sales of health products and supplements.

Number of employees: 96

Sales per Business

HKD in Million2021Weight2022Weight Delta
Biological Reagents and Auxiliary Reproductive Supplies and Equipment
91.5 %
28 89.3 % 27 91.5 % -4.14%
Healthcare Products and Supplements
8.5 %
3 10.7 % 3 8.5 % -25.78%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
31 100.0 % 29 100.0 % -6.46%

Managers

Managers TitleAgeSince
Chun Guang Zhang CEO
 Chief Executive Officer 56 17-08-02
Lai Yin Poon DFI
 Director of Finance/CFO 52 17-08-02
Jia Ming He BRD
 Director/Board Member 38 18-12-31
Lai Ki Chau AUD
 Comptroller/Controller/Auditor 41 17-08-31

Members of the board

Members of the board TitleAgeSince
Lai Yin Poon DFI
 Director of Finance/CFO 52 17-08-02
Faat Ting Cheng BRD
 Director/Board Member 56 20-08-31
Kwok Fai Joseph Chow BRD
 Director/Board Member 51 20-12-15
Shu Guang Zhang CHM
 Chairman 53 17-08-02
Chun Guang Zhang CEO
 Chief Executive Officer 56 17-08-02
Jia Ming He BRD
 Director/Board Member 38 18-12-31
Ching Man Chow BRD
 Director/Board Member 39 23-08-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 500,472,000 285,048,000 ( 56.96 %) 0 56.96 %

Company contact information

Huakang Biomedical Holdings Co. Ltd.

Room 04, 9 Floor, Kimberley House 35-35A Kimberley

, Kowloon

+

http://www.huakangbiomedical.com/en/index.html
address Huakang Biomedical Holdings Company Limited(8622)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED Stock Huakang Biomedical Holdings Company Limited
-8.41% 6.27M
BIOMÉRIEUX Stock bioMérieux
-0.60% 12.63B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.67B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.82% 5.42B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+7.32% 4.56B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-47.68% 3.51B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.59B
VITROLIFE AB Stock Vitrolife AB
-14.59% 2.05B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+2.25% 1.77B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 8622 Stock
  4. Company Huakang Biomedical Holdings Company Limited